Blockade of angiotensin converting enzyme but not of angiotensin AT1 receptors improves glucose tolerance

European Journal of Pharmacology

Volumn 319, Issue 1, 1997, Pages 77-83

  Chow, Larry ^a   De Gasparo, Marc ^a   Levens, Nigel ^a  

^a CIBA GEIGY LTD   (Switzerland)

Author keywords

Angiotensin AT1 receptor antagonist; Angiotensin converting enzyme inhibitor; Blood pressure; Glucose tolerance; Spontaneously hypertensive rat (SHR); Valsartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VALSARTAN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE TOLERANCE TEST; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BENZAZEPINES; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; GLUCOSE TOLERANCE TEST; INSULIN; MALE; RATS; RATS, INBRED SHR; RECEPTORS, ANGIOTENSIN; TETRAZOLES; VALINE; WEIGHT GAIN;

EID: 0031566867     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00823-0     Document Type: Article

References (31)

1. Armitage, P. and G. Berry, 1987, Comparison of several groups, in: Statistical Methods in Medical Research, 2nd edn. (Blackwell Scientific Publications, Oxford) p. 186.
2. Berne, C., 1991, Metabolic effects of ACE inhibitors, J. Intern. Med. Suppl. 735, 119.
3. Bursztyn, M., D. Ben-Ishay and A. Gutman, 1992, Insulin resistance in spontaneously hypertensive rats but not in secondary hypertension in the rat, deoxycorticosterone-salt or renal vascular hypertension, J. Hypertens. 10, 137.
4. 1 receptors, Eur. J. Pharmacol. 282, 77.
5. Cox, J.E., W.B. Laughton and T.L. Powley, 1985, Precise estimation of carcass fat from total body water in rats and mice, Physiol. Behav. 35, 905.
6. 1-receptor subtype, Br. J. Pharmacol. 110, 761.
7. De Feo, P., E. Torlone, G. Perriello, C. Fanelli, L. Epifano, A. Di Vincenzo, F. Modarelli, M. Motolese, P. Brunetti and G.B. Bolli, 1992, Diabetes Metab. 18, 283.
8. Dyer, S.M., D.B. Frewin and R.J. Head, 1992, The influence of chronic captopril treatment and its withdrawal on endothelium-dependent relaxation, Blood Pressure 1, 247.
9. Ferrannini, E., S.M. Haffner, B.D. Mitchell and M.P. Stern, 1990, Essential hypertension: an insulin resistant state, J. Cardiovasc. Pharmacol. 15 (Suppl. 5), S18.
10. Ferrannini, E., G. Seghieri and E. Muscelli, 1994, Insulin and the renin-angiotensin-aldosterone system: Influence of ACE inhibition, J. Cardiovasc. Pharmacol. 24 (Suppl. 3), S61.
11. Frankson, J.R.H., H.A. Ooms, R. Ballans, V. Conard and P.A. Bastenie, 1962, Physiologic significance of the intravenous glucose tolerance test, Metabolism 11, 482.
12. Harrap, S.B., W.M. Van der Merwe, S.A. Griffin, F. Macpherson and A.F. Lever, 1990, Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long term, Hypertension 16, 603.
13. Henriksen, E.J., S. Jacob, H.J. Augustin and G.J. Dietze, 1996, Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism, Diabetes 45 (Suppl. 1), S125.
14. Lundbaek, K., 1962, Intravenous glucose tolerance as a tool in definition and diagnosis of diabetes mellitus, Br. Med. J. 1, 1507.
15. McGiff, J.C., N.A. Terragno, K.U. Malik and A.J. Lonigro, 1972, Release of a prostaglandin E-like substance from canine kidney by bradykinin, Circ. Res. 31, 36.
16. Moan, A., A. Hoieggen, G. Nordby, I.K. Eide and S.E. Kjeldsen, 1995, Effects of losartan on insulin sensitivity in severe hypertension: connections through sympathetic nervous system activity?, J. Hum. Hypertens. 9 (Suppl. 5), S45.
17. Moan, A., T. Risanger, I. Eide and S.E. Kjeldsen, 1994, The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous system activity in primary hypertension, Blood Pressure 3, 185.
18. Osksa, A., M. Gajdos, V. Fedelesova, V. Spustova and R. Dzurik, 1994, Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension, J. Cardiovasc. Pharmacol. 23, 79.
19. Pellacani, A, H.R. Brunner and J. Nussberger, 1994, Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects, Clin. Sei. 87, 567.
20. Pollare, T., H. Lithell, I, Selinus and C. Berne, 1988, Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension, Diabetologica 31, 415.
21. Reaven, G.M., 1990, Role of abnormalities of carbohydrate and lipoprotein metabolism in the pathogenesis and clinical course of hypertension, J. Cardiovasc. Pharmacol. 15 (Suppl. 5), S4.
22. Reaven, G.M., 1994, Syndrome X-6 years later, J. Intern. Med. 236, 13.
23. Rett, K., M. Wicklmayr, G. J. Dietze and H. U. Haring, 1996, Insulin-induced glucose transporter (GLUT1) and GLUT4) translocation in cardiac muscle tissue is mimicked by bradykinin, Diabetes 45 (Suppl. 1), S66.
24. Santoro, D., A. Natali and C. Palombo, I.S. Brandi, M. Piatti, S. Ghione and E. Ferrannini, 1992, Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension, Hypertension 20, 181.
25. Thybo, N.K., N. Kongaard, S. Eriksen, K.L. Christensen, and M.J. Mulvany, 1994, Dose-dependent effects of perindopril on blood pressure and small artery structure, Hypertension 23, 659.
26. Timmermans, P.B., P.C. Wong, A.T. Chiu, W.F. Herblin, P. Benfield, D.J. Carini, R.R. Wexler, J.A. Saye and R.S.D. Smith, 1993, Angiotensin II receptors and angiotensin II receptor antagonists, Pharmacol. Rev. 45, 205.
27. Tomiyama, H., T. Kushiro, Z.H. Abeta, T. Ishii, A. Takahashi, Z. I. Furukawa, T. Asagami, T. Hino, F. Saito, Y. Otsuka, H. Kurumatani, F. Kobayashi, K. Kanmatsue and N. Kajiweara, 1994, Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitors, Hypertension 23, 450.
28. Tufro-McReddie, A., D.W. Johns, K. M. Geary, H. Dagli, A. D. Everett, R. L. Chevalier, R.M. Carey and R.A. Gomez, 1994, Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development, Am. J. Physiol. 266, F911.
29. Uehara, M., H. Kishikawa, S. Isami, K. Kisanuki, Y. Ohkubo, N. Miyamura, T. Miyata, T. Yano and M. Shichiri, 1994, Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans, Diabetologia 37, 300.
30. Vacher, E., P. Fornes, C. Richer, P. Bruneval, D. Nisato, J.F. Giudicelli, 1995, Early and late haemodynamic and morphological effects of angiotensin II subtype 1 receptor blockade during genetic hypertension development, J. Hypertens. 13, 675.
31. Zhang, B., K. Saku, K. Hirata, R. Liu, K. Tateishi, M. Shiomi, K. Arakawa, 1994, Quantitative characterization of insulin-glucose response in Watanabe heritable hyperlipidemic and cholesterol-fed rabbits and the effect of cilazapril, Metabolism 43, 360.